
10th R&D Procurement & Sourcing in Pharma Summit 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 10th R&D Procurement & Sourcing in Pharma Summit 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
10th R&D Procurement & Sourcing in Pharma Summit 2026
Event Overview
The 10th R&D Procurement & Sourcing in Pharma Summit 2026 is a premier event designed to bring together industry leaders, procurement professionals, and sourcing experts within the pharmaceutical sector. This summit aims to address the latest trends, challenges, and opportunities in research and development procurement and sourcing, fostering collaboration and innovation.
Who Attends?
The summit attracts a diverse group of attendees including:
- Procurement Directors and Managers
- Sourcing and Supply Chain Leaders
- R&D Executives and Managers
- Pharmaceutical and Biotech Industry Professionals
- Regulatory Affairs Specialists
- Consultants and Analysts in Pharma Procurement
- Technology and Solution Providers
Location & Attendee Geographic Origin
The summit will be held at the Grand Hyatt, San Francisco, California, USA. Attendees primarily originate from North America, with significant participation from Europe and Asia, reflecting the global nature of the pharmaceutical industry.
Audience Reach
This is a global event with attendees from major pharmaceutical hubs worldwide, offering a unique opportunity to network with international leaders in R&D procurement and sourcing.
Sample Buyer Company Names & Websites
- Pfizer - pfizer.com
- Novartis - novartis.com
- Roche - roche.com
- Sanofi - sanofi.com
- GSK - gsk.com
- AstraZeneca - astrazeneca.com
- Johnson & Johnson - jnj.com
Job Profiles, Industries & Event Type
The summit is ideal for professionals in the following roles and industries:
- Procurement & Sourcing Directors in Pharmaceuticals
- R&D Project Managers
- Supply Chain Analysts
- Biotechnology Researchers
- Regulatory Compliance Officers
- Pharma Industry Consultants
Estimated Attendance
The summit is expected to attract over 500 attendees, including industry leaders, decision-makers, and innovators from across the pharmaceutical procurement and sourcing landscape.
Key Focus Areas & Buyer Engagement
Key focus areas include:
- Optimizing R&D Procurement Strategies
- Enhancing Supplier Relationships
- Innovations in Pharma Sourcing Technologies
- Regulatory and Compliance Challenges in Sourcing
- Cost Reduction and Value Maximization
The summit provides an excellent platform for engaging with top-tier pharmaceutical companies and exploring new business opportunities.
Data sheet
| Event Name | 10th R&D Procurement & Sourcing in Pharma Summit 2026 |
| Event Date | 2 June 2026 - 4 June 2026 |
| Event Status | Completed |
| Venue | Boston venue not publicly confirmed in the provided brief; city-level location confirmed by user input. |
| City | Boston |
| State / Region | Massachusetts |
| Country | United States |
| Organizer | Organizer not independently verified in this research snapshot. |
| Official Event Website | Official event website not independently verified in this research snapshot. |
| Event Type | B2B summit / conference focused on procurement, sourcing, supplier management, and R&D operations in pharma and biotech. |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Business Services; Science & Research |
| Audience Reach | Likely national-to-global, given Boston’s concentration of pharma, biotech, CRO, CDMO, and life sciences procurement stakeholders. |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for quantitative attendance metrics; moderate for thematic audience profile based on event title, location, and sector relevance. |
| Main Purpose of Event | To convene pharmaceutical and biotech procurement, sourcing, supplier management, outsourcing, and R&D operations leaders to discuss supplier strategy, innovation partnerships, risk management, cost control, compliance, and external research service procurement. |
The 10th R&D Procurement & Sourcing in Pharma Summit 2026 is a niche B2B conference centered on how pharmaceutical and biotech organizations source research services, scientific suppliers, laboratory support, clinical and preclinical partners, digital tools, and specialist outsourced capabilities. The event theme suggests a senior audience drawn from procurement, strategic sourcing, external innovation, supplier relationship management, category management, and R&D operations.
This type of summit matters because R&D procurement decisions directly affect speed to science, supplier quality, compliance, cost efficiency, data integrity, and innovation access. For lead generation, it is generally more valuable than a broad life sciences trade show when the goal is to reach decision-makers involved in CRO/CDMO selection, lab supply sourcing, technology buying, outsourcing governance, and strategic supplier partnerships.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Strategic sourcing leaders | Large pharma, biotech, vaccine, specialty therapeutics firms | Own category strategy, supplier panels, RFPs, and vendor selection | High-value targets for CROs, CDMOs, lab suppliers, software, and advisory services |
| Procurement directors and managers | Pharma and life sciences operating companies | Run sourcing processes, contract negotiations, supplier onboarding, and spend governance | Core buying audience for procurement-led solutions and outsourced services |
| R&D operations leaders | Research centers, discovery units, translational research teams | Specify technical needs and influence final supplier selection | Important technical approvers for scientific services and platforms |
| External innovation / alliance management teams | Biopharma companies partnering with academia, startups, and specialist providers | Assess strategic partnerships, scouting, and collaboration models | Relevant for platform providers, data partners, and co-development service firms |
| Supply chain and category managers | Global sourcing organizations, laboratory operations, manufacturing-linked R&D support teams | Manage spend categories such as lab supplies, analytical services, clinical services, and digital tools | Useful for category-specific outreach and account mapping |
| Quality, compliance, and vendor governance leaders | GxP-regulated pharma and biotech organizations | Influence approved supplier lists, qualification criteria, and audit requirements | Critical stakeholders where compliance and validation are key buying barriers |
| Digital procurement and technology leaders | Enterprises modernizing procurement workflows and supplier data processes | Evaluate source-to-contract, supplier risk, analytics, AI, and spend tools | Relevant for procurement software, data, cybersecurity, and workflow providers |
| Consultants and advisory firms | Procurement consulting, life sciences strategy, outsourcing advisory firms | Influence transformation projects and vendor shortlists | Useful channel and referral relationships, but not always direct buyers |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Boston metro | Local pharma, biotech, research, and venture-backed life sciences ecosystem | Very high | Boston/Cambridge is one of the strongest U.S. clusters for drug discovery and biotech procurement stakeholders. |
| Massachusetts / New England | Regional life sciences companies, universities, research hospitals, and service partners | High | Strong draw for regional procurement and R&D operations leaders. |
| U.S. Northeast corridor | New York, New Jersey, Pennsylvania, Maryland, and broader East Coast life sciences buyers | High | Likely source of procurement decision-makers from major pharma and outsourced service ecosystems. |
| National U.S. | Buyers from California, North Carolina, Illinois, Texas, and other biotech/pharma hubs | Medium to high | Expected where summit agenda is strategic rather than purely local. |
| Europe | Global category leaders, sourcing heads, and multinational pharma teams | Medium | Likely if the summit serves multinational organizations and global sourcing mandates. |
| Asia-Pacific | Selective participation from multinational sourcing, supplier, or outsourcing teams | Low to medium | International reach is plausible but not independently confirmed. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The summit theme is relevant to multinational pharma and biotech procurement functions with global supplier networks, even though current-year attendance geography was not publicly confirmed. |
| National | Secondary reach description | Boston is likely to draw a strong U.S. audience across major life sciences hubs. |
| Regional | Secondary reach description | The New England and Northeast concentration of pharma and biotech companies likely supports strong regional participation. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Pfizer | Global pharmaceutical manufacturer | Large-scale R&D sourcing, clinical procurement, and strategic supplier management functions | pfizer.com | Director Procurement, Category Lead, VP Sourcing, Supplier Relationship Manager | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Global pharmaceutical company | Relevant for global category management, external research partnerships, and procurement transformation | novartis.com | Head of Procurement, Global Category Manager, Sourcing Director | Strong Market Fit, Attendance Not Confirmed |
| Roche | Global pharma and diagnostics buyer | Significant buyer of research, lab, and digital capabilities supporting R&D | roche.com | Procurement Director, Supplier Manager, Category Manager, R&D Operations Leader | Strong Market Fit, Attendance Not Confirmed |
| Sanofi | Global pharmaceutical buyer | Active in R&D procurement categories including CRO, lab services, and supplier innovation | sanofi.com | Strategic Sourcing Lead, Procurement Manager, Alliance Manager | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Global biopharma buyer | Likely interest in supplier ecosystems supporting discovery, development, and digital R&D operations | astrazeneca.com | Global Sourcing Director, Procurement Business Partner, Category Lead | Strong Market Fit, Attendance Not Confirmed |
| Johnson & Johnson Innovative Medicine | Global pharma buyer | Large enterprise with significant spend across scientific services, research partnerships, and procurement systems | jnj.com | Procurement Director, Supplier Governance Lead, Category Manager | Strong Market Fit, Attendance Not Confirmed |
| Merck & Co. | Global pharmaceutical buyer | Relevant for preclinical, clinical, lab, and digital procurement categories | merck.com | R&D Procurement Lead, Director Strategic Sourcing, SRM Lead | Strong Market Fit, Attendance Not Confirmed |
| Bristol Myers Squibb | Biopharma buyer | Strong fit for outsourced research, procurement modernization, and category buying | bms.com | Category Manager, Procurement Director, R&D Operations Manager | Strong Market Fit, Attendance Not Confirmed |
| Biogen | Boston-area biopharma buyer | Local strategic fit with significant R&D and supplier ecosystem activity | biogen.com | Procurement Manager, Sourcing Director, Alliance Management Lead | Strong Market Fit, Attendance Not Confirmed |
| Takeda | Global biopharmaceutical buyer | Boston/Cambridge presence and broad R&D sourcing relevance | takeda.com | Head of Procurement, Category Lead, Supplier Excellence Manager | Strong Market Fit, Attendance Not Confirmed |
| Moderna | Boston-area biotech buyer | Strong local fit for supplier innovation, clinical support, and advanced R&D sourcing | modernatx.com | Sourcing Manager, Procurement Director, External Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| Vertex Pharmaceuticals | Boston-area biopharma buyer | Relevant for research services, lab procurement, and category sourcing in a major local life sciences hub | vrtx.com | Procurement Lead, Lab Operations Buyer, Strategic Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Procurement Officer | Procurement | C-Level | Sets sourcing strategy, supplier governance, and enterprise procurement priorities. |
| 2 | VP Procurement / VP Strategic Sourcing | Procurement | VP | Owns category oversight, outsourcing strategy, and supplier portfolio management. |
| 3 | Director of Procurement | Procurement | Director | Drives sourcing projects and shortlist decisions for approved suppliers. |
| 4 | Strategic Sourcing Manager | Procurement / Supply Chain | Manager | Often directly involved in RFIs, RFPs, negotiations, and supplier evaluation. |
| 5 | Category Manager | Procurement | Manager / Director | Controls spend categories such as CRO, lab services, software, and scientific supplies. |
| 6 | Supplier Relationship Manager | Procurement / Vendor Management | Manager / Director | Key for expansion inside approved accounts and long-term supplier performance programs. |
| 7 | R&D Operations Director | R&D Operations | Director | Technical stakeholder influencing supplier suitability, workflow fit, and implementation. |
| 8 | Head of External Innovation / Alliances | Business Development / R&D | Director / VP | Important for platform partnerships, co-development, and specialized outsourcing relationships. |
| 9 | Vendor Governance / Quality Lead | Quality / Compliance | Manager / Director | Influences approved vendor status, audits, and risk acceptance. |
| 10 | Procurement Systems / Digital Procurement Leader | IT / Procurement Excellence | Director / Head | Relevant for source-to-pay tools, spend analytics, AI, and supplier data platforms. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Primary buyer base for R&D procurement and sourcing in pharma | Target enterprise drug developers and specialty pharma buyers |
| 2 | Biotechnology | Strong relevance in Boston/Cambridge innovation ecosystem | Target emerging and mid-market biotech procurement leaders |
| 3 | Medical Devices | Adjacent regulated buyers with R&D and supplier management functions | Expand to device innovators with scientific sourcing needs |
| 4 | Hospital & Health Care | Relevant for translational research hospitals and innovation centers | Target research procurement and clinical innovation teams |
| 5 | Research | Applies to contract research institutes and advanced scientific organizations | Reach scientific organizations with external vendor spend |
| 6 | Information Technology & Services | Relevant where the offer supports digital procurement, analytics, compliance, or workflow automation | Target procurement transformation and systems stakeholders |
| 7 | Computer Software | Useful if selling source-to-contract, supplier risk, AI, or spend tools to pharma buyers | Build technology-buyer segments inside life sciences accounts |
| 8 | Management Consulting | Consultancies often shape procurement redesign and supplier selection frameworks | Channel influence and advisory-led market access |
| 9 | Business Supplies & Equipment | Relevant for organizations buying scientific and operational support products | Lab support and operational procurement targeting |
| 10 | Outsourcing/Offshoring | Relevant where research support, analytics, or specialized service delivery is outsourced | Target buyers managing external service models |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No verified public attendance source available in this snapshot | Do not use a numeric claim in sales material without organizer confirmation. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified exhibitor directory reviewed | Event appears conference-led rather than broad expo-led. |
| Buyer count | Not publicly confirmed | Unconfirmed | No verified registration or hosted buyer source reviewed | Buyer quality is likely stronger than buyer volume due to niche focus. |
| Speaker count | Not publicly confirmed | Unconfirmed | No verified agenda source reviewed | Speaker organizations could materially improve account-based targeting if sourced later. |
| Sponsor count | Not publicly confirmed | Unconfirmed | No verified sponsor listing reviewed | Sponsors are more likely to be vendors than buyers. |
| Historical attendance | Historical attendance not verified | Historical / prior-year evidence unavailable | No validated prior-year public attendance source reviewed | If required, obtain official brochures or archived summit pages. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| R&D procurement strategy | Reduce cost while maintaining scientific quality and supplier agility | Executive discussions around category strategy and sourcing models | Procurement advisory, benchmarking, strategic sourcing support |
| CRO / CDMO / external service sourcing | Identify reliable specialist partners and improve vendor oversight | Account-based outreach to procurement and alliance teams | Research services, development services, manufacturing support |
| Supplier risk and compliance | Manage quality, audit readiness, data integrity, and continuity risk | Target vendor governance, QA, and compliance stakeholders | Risk platforms, validation support, compliance services |
| Digital procurement transformation | Improve visibility, spend control, approvals, and supplier data quality | Software demos and transformation-led conversations | Source-to-contract, e-procurement, spend analytics, AI tools |
| Innovation partner discovery | Access emerging capabilities, niche science, and specialized vendors | Thought-leadership outreach to R&D and external innovation leaders | Specialized platforms, discovery tools, translational research services |
| Laboratory operations and scientific supplies | Secure reliable supply, improve standardization, and support productivity | Category manager and lab operations targeting | Lab equipment, consumables, inventory, and support services |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The summit theme is directly aligned to procurement and sourcing decision-makers in pharma and biotech. |
| Decision-maker availability | High | Niche procurement summits usually attract more senior and functional leaders than general trade shows. |
| Data collection potential | Medium | Good potential if speaker, attendee, sponsor, or partner lists can be sourced; current public verification is limited. |
| Apollo targeting potential | Very High | Job function, industry, and geography filters map well to pharma procurement buyers. |
| Geographic targeting potential | High | Boston, Cambridge, New Jersey, Philadelphia, and major biotech hubs provide clear target clusters. |
| Best outreach approach | High | Use account-based outreach tied to supplier risk, R&D efficiency, category performance, and innovation sourcing outcomes. |
| Overall lead quality | High | Particularly strong for vendors serving life sciences procurement, lab operations, outsourced R&D, and supplier management. |
| Best use case | High | ABM list building, buyer persona mapping, speaker/account capture, and category-led outbound prospecting. |
| Limitations / risks | Medium | Limited publicly verified attendance data reduces certainty around current-year account confirmation. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Medical Devices; Hospital & Health Care; Research; Information Technology & Services; Computer Software; Management Consulting | Focus on regulated life sciences buyers and procurement-enabling stakeholders |
| Departments | Procurement, Supply Chain, Operations, Research, Business Development, Information Technology, Quality Assurance | Capture both commercial buyers and technical influencers |
| Seniority | C-Level, VP, Director, Head, Manager | Prioritize decision-makers and category owners |
| Job titles | Chief Procurement Officer, VP Procurement, VP Strategic Sourcing, Director of Procurement, Strategic Sourcing Manager, Category Manager, Supplier Relationship Manager, R&D Operations Director, Head of External Innovation, Procurement Excellence Lead | Reach the most relevant buying and influence roles |
| Geography | United States; Massachusetts; Boston; Cambridge; New Jersey; Pennsylvania; California; North Carolina; Switzerland; United Kingdom; Germany | Balance local event relevance with global pharma account coverage |
| Employee size | 201-500; 501-1000; 1001-5000; 5001-10000; 10000+ | Covers scaling biotech through large global pharma enterprises |
| Keywords | R&D procurement, strategic sourcing, category management, supplier relationship management, external innovation, CRO, CDMO, lab operations, vendor governance, procurement excellence | Refine account and contact relevance |
| Technologies, if relevant | Procurement software, source-to-pay, CLM, spend analytics, supplier risk management, e-sourcing | Useful for selling digital procurement or data solutions |
| Revenue range, if relevant | $50M+ for biotech; $500M+ for enterprise pharma campaigns | Focus on organizations with formal procurement structures |
| Company type | Public companies, private companies, venture-backed biotech, multinational subsidiaries | Expand list quality across maturity stages |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Client input | Event title, city, region, country, and event dates | Moderate |
| Boston life sciences ecosystem references | Market context | Supports geographic relevance of Boston/Cambridge for pharma and biotech buyer concentration | Moderate |
| Corporate websites such as Pfizer, Novartis, Roche, Takeda | Company websites | Organization identity and website domains only; not attendance confirmation | High for company existence; low for event participation |
| Verification note | Research limitation | Organizer website, venue detail, speaker list, sponsor list, and attendee list were not independently verified in this research snapshot | High transparency |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 10th R&D Procurement & Sourcing in Pharma Summit 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.